TARC before ASCT Is Highly Predictive of Outcome in Patients with Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL) after First-Line Therapy
暂无分享,去创建一个
P. Corradini | A. Guidetti | L. Farina | A. Gianni | S. Viviani | F. Crippa | A. Mazzocchi | M. Magni | P. Matteucci | M. Nicola | A. Dodero | F. Spina | L. Devizzi | M. Galbiati